Total Visits

Views
A phase II study of capecitabine in combination with erlotinib as first-line therapy in patients with metastatic pancreatic cancer (stage IV)61

Select a period of time:

Views

Views
July 20221
August 20222
September 20221
October 20224
November 20225
December 20222
January 202314
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States18
Ireland11
 

Top cities views

Views
Dublin11
San Ramon8
Louisville4
Ashburn3
Des Moines2
San Diego1